- Home
- EPSM vs ECOR Comparison
EPSM vs ECOR Comparison
Compare EPSM & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPSM
- ECOR
- Stock Information
- Founded
- EPSM 2010
- ECOR 2005
- Country
- EPSM China
- ECOR United States
- Employees
- EPSM N/A
- ECOR N/A
- Industry
- EPSM
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- EPSM
- ECOR Health Care
- Exchange
- EPSM Nasdaq
- ECOR Nasdaq
- Market Cap
- EPSM 71.3M
- ECOR 57.5M
- IPO Year
- EPSM 2025
- ECOR 2018
- Fundamental
- Price
- EPSM $4.95
- ECOR $6.62
- Analyst Decision
- EPSM
- ECOR Strong Buy
- Analyst Count
- EPSM 0
- ECOR 2
- Target Price
- EPSM N/A
- ECOR $25.50
- AVG Volume (30 Days)
- EPSM 577.3K
- ECOR 217.3K
- Earning Date
- EPSM 01-01-0001
- ECOR 03-12-2025
- Dividend Yield
- EPSM N/A
- ECOR N/A
- EPS Growth
- EPSM N/A
- ECOR N/A
- EPS
- EPSM 0.05
- ECOR N/A
- Revenue
- EPSM $17,906,283.00
- ECOR $25,182,000.00
- Revenue This Year
- EPSM N/A
- ECOR $40.88
- Revenue Next Year
- EPSM N/A
- ECOR $48.01
- P/E Ratio
- EPSM $94.28
- ECOR N/A
- Revenue Growth
- EPSM N/A
- ECOR 57.09
- 52 Week Low
- EPSM $4.23
- ECOR $5.32
- 52 Week High
- EPSM $6.34
- ECOR $19.49
- Technical
- Relative Strength Index (RSI)
- EPSM N/A
- ECOR 22.94
- Support Level
- EPSM N/A
- ECOR $6.04
- Resistance Level
- EPSM N/A
- ECOR $7.05
- Average True Range (ATR)
- EPSM 0.00
- ECOR 0.74
- MACD
- EPSM 0.00
- ECOR -0.03
- Stochastic Oscillator
- EPSM 0.00
- ECOR 14.87
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.